| 11. |
Early versus late tirofiban after MI: no difference in outcomes |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 12. |
Insulin detemir shows reduced intrapatient variability |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 14-14
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 13. |
Misoprostol demonstrates route-dependent pharmacokinetics and is best absorbed via vaginal administration, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 15-15
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 14. |
The prevalence of birth defects afterin uteronelfinavir exposure does not differ significantly from the population-based prevalence, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 16-16
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 15. |
EU product launches |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 17-17
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 16. |
US product launches |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 18-18
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 17. |
Product Introductions |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1445,
2004,
Page 19-19
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
